The researchers conducted a meta-analysis, combining data from 122 studies, to assess the cognitive effects of psychedelics and MDMA Their focus was on three cognitive domains: memory, executive ...

Shares of companies developing treatments based on psilocybin and other psychedelic drugs moved lower on Monday after the U.S. Food and Drug Administration rejected use of MDMA for post-traumatic ...

US drugmaker Lykos Therapeutics is cutting most of its staff after the Food and Drug Administration rejected its MDMA drug for mental health treatments. Lykos will lay off 75% of its staff, or about ...

Few compounds better illustrate the tension between therapeutic promise, regulatory skepticism, abuse liability, and political momentum surrounding post-traumatic stress disorder (PTSD) than the drug ...

Researchers have been looking into whether psychedelics could be used to treat PTSD. Currently, only therapy and two antidepressant medications are approved to treat the condition. PYMCA / Avalon / ...

Taking antidepressant medication at the same time as MDMA is associated with a lower rate of fatal outcomes compared to other drug-related deaths. These findings provide baseline safety data for ...

WASHINGTON — A bipartisan group of federal lawmakers are pushing the Food and Drug Administration to approve using MDMA, also known as ecstasy, as a treatment for veterans suffering from ...

Lykos Therapeutics is cutting 75% of staff after FDA rejected its MDMA drug for mental health. The FDA's decision marks the first time the agency considered a psychedelic for medical use. Lykos plans ...